Richard Orgill, MD
Otolaryngology · Oklahoma City, OKNPI 1063463669
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $976 of the $1,581 with a category attached, or 61.7%. Medtronic accounts for 61.8% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $993, more than ten times the $43 reported in 2019.
Across 41 payments — averaging $38.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$977
- GSK$255
- Stryker$146
- Regeneron Healthcare Solutions, Inc.$72
- Merck$36
- Bausch & Lomb, A Division Of Bausch Health US, LLC$19
- plus $77 from 5 others
What the payments were for
- Travel & lodging$60538%
- Food & beverage$97662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 12 | $977 |
| GSK | 11 | $255 |
| Stryker | 6 | $146 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| Merck | 2 | $36 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Alk-abello, Inc | 1 | $16 |
| Intersect ENT, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,581 in reported general payments places this provider in the 55th percentile of 109 otolaryngology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 479 | $7,542 |
| Azelastine Hcl | 127 | $3,945 |
| Ipratropium Bromide | 80 | $1,903 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 19 | $1,895 |
| Pantoprazole Sodium | 123 | $1,873 |
| Montelukast Sodium | 143 | $1,849 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 94 | $1,500 |
| Clorazepate Dipotassium | 25 | $1,340 |
| Dexamethasone Sodium Phosphate | 32 | $1,234 |
| Ofloxacin | 59 | $890 |
| Mometasone Furoate | 54 | $481 |
| Doxycycline Hyclate | 31 | $417 |
| Nortriptyline Hcl | 56 | $374 |
| Prednisone | 168 | $310 |
| Ondansetron OdtOndansetron | 30 | $274 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Oklahoma City
- Kibwei McKinneyOklahoma City$315K
- Richard BakerOklahoma City$17K
- Edward El RassiOklahoma City$13K
- Benjamin CollinsOklahoma City$10K
- Keith ClarkOklahoma City$6K
- Rachad MhawejOklahoma City$6K
- John HouckOklahoma City$5K
- Matthew SharumOklahoma City$5K
- Hassan HawsawiOklahoma City$5K
- Brandon PiersonOklahoma City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.